Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03313466 · ClinicalTrials.gov registry record · NA

Trial of Internet-Based Cognitive Behavioral Therapy for Insomnia

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
136,630
Enrollment target

NCT03313466: Completed NA study, sponsored by Kaiser Permanente.

NCT03313466 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 136,630 participants, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (9652% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03313466, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
136,630 participants
Enrollment target

Study Summary

The investigators will conduct a randomized, controlled trial of internet-based cognitive behavioral therapy (iCBT) vs usual care for insomnia. The target population is patients prescribed medications for insomnia who have not had a dispensation of these medications in the preceding six months. The primary outcomes is dispensed days supply over the subsequent one year. Secondary outcomes include all types of health system clinical encounters. The investigators hypothesize that the group randomized into iCBT will have less insomnia medications dispensed than usual care controls, and less clinical encounters..

Primary Outcome

Days supply of dispensed insomnia medications up to one year after randomization.

Interventions

  • BEHAVIORAL Internet cognitive behavioral therapy for insomnia (iCBTI)
  • BEHAVIORAL Class in sleeping well and improving insomnia

Trial Details

FieldValue
Enrollment Target 136,630 participants
Start Date 2018-03-13
Est. Completion 2019-06-19
Phase NA
Kaiser Permanente

294 total trials

What the finished NCT03313466 record still lists

NCT03313466 is an interventional study that assigns participants to a tested intervention. Its 136,630 participants enrollment target places it among the larger protocols in the corpus, above the 1,401-participant average among 58,714 other NA trials with a reported enrollment target (9652% higher).

The record links to 0 conditions, and to 2 interventions - of which Internet cognitive behavioral therapy for insomnia (iCBTI) is the first listed.

NCT03313466 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03313466 about?

NCT03313466 is a clinical study titled "Trial of Internet-Based Cognitive Behavioral Therapy for Insomnia". The investigators will conduct a randomized, controlled trial of internet-based cognitive behavioral therapy (iCBT) vs usual care for insomnia. The target population is patients prescribed medications for insomnia who have not had a dispensation of these medications in the preceding six months. The ...

What is the current status of trial NCT03313466?

This trial is currently completed. It is a NA study. The enrollment target is 136,630 participants. The study started on 2018-03-13. Estimated completion is 2019-06-19.

What interventions are being tested in trial NCT03313466?

The interventions under investigation include: Internet cognitive behavioral therapy for insomnia (iCBTI) (BEHAVIORAL), Class in sleeping well and improving insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT03313466?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03313466's enrollment target sits among peer trials

136,630 2nd of 2000 the highest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05994482 · 130,000 participants

    Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study

  • NCT02693509 · 128,026 participants

    Get With The Guidelines-Heart Failure Registry

  • NCT06232551 · 152,000 participants · NA

    Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

  • NCT03897374 · 120,000 participants

    Strategic Targeting for Optimal Prevention of Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03313466, the US trial registry maintained by the National Library of Medicine. NCT03313466 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.